Efficacy and safety of standard versus low dose solifenacin and trospium in elderly patients with moderate overactive bladder symptoms

Trial Profile

Efficacy and safety of standard versus low dose solifenacin and trospium in elderly patients with moderate overactive bladder symptoms

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Sep 2015

At a glance

  • Drugs Solifenacin (Primary) ; Trospium chloride (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top